Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-34, a comprehensive review.
Baghdadi M, Umeyama Y, Hama N, Kobayashi T, Han N, Wada H, Seino KI. Baghdadi M, et al. Among authors: han n. J Leukoc Biol. 2018 Nov;104(5):931-951. doi: 10.1002/JLB.MR1117-457R. Epub 2018 Aug 1. J Leukoc Biol. 2018. PMID: 30066957 Review.
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells.
Baghdadi M, Wada H, Nakanishi S, Abe H, Han N, Putra WE, Endo D, Watari H, Sakuragi N, Hida Y, Kaga K, Miyagi Y, Yokose T, Takano A, Daigo Y, Seino KI. Baghdadi M, et al. Among authors: han n. Cancer Res. 2016 Oct 15;76(20):6030-6042. doi: 10.1158/0008-5472.CAN-16-1170. Epub 2016 Aug 22. Cancer Res. 2016. PMID: 27550451 Free article.
Prognostic value of IL-34 in colorectal cancer patients.
Kobayashi T, Baghdadi M, Han N, Murata T, Hama N, Otsuka R, Wada H, Shiozawa M, Yokose T, Miyagi Y, Takano A, Daigo Y, Seino KI. Kobayashi T, et al. Among authors: han n. Immunol Med. 2019 Dec;42(4):169-175. doi: 10.1080/25785826.2019.1691429. Epub 2019 Nov 23. Immunol Med. 2019. PMID: 31762401
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade.
Hama N, Kobayashi T, Han N, Kitagawa F, Kajihara N, Otsuka R, Wada H, Lee HK, Rhee H, Hasegawa Y, Yagita H, Baghdadi M, Seino KI. Hama N, et al. Among authors: han n. iScience. 2020 Sep 19;23(10):101584. doi: 10.1016/j.isci.2020.101584. eCollection 2020 Oct 23. iScience. 2020. PMID: 33205010 Free PMC article.
Erratum: Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade.
Hama N, Kobayashi T, Han N, Kitagawa F, Kajihara N, Otsuka R, Wada H, Lee HK, Rhee H, Hasegawa Y, Yagita H, Baghdadi M, Seino KI. Hama N, et al. Among authors: han n. iScience. 2022 Jan 5;25(1):103713. doi: 10.1016/j.isci.2021.103713. eCollection 2022 Jan 21. iScience. 2022. PMID: 35028541 Free PMC article.
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor.
Nakamura T, Kajihara N, Hama N, Kobayashi T, Otsuka R, Han N, Wada H, Hasegawa Y, Suzuki N, Seino KI. Nakamura T, et al. Among authors: han n. J Gynecol Oncol. 2023 May;34(3):e25. doi: 10.3802/jgo.2023.34.e25. Epub 2022 Dec 21. J Gynecol Oncol. 2023. PMID: 36603850 Free PMC article.
2,201 results